Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 2
2007 2
2008 2
2009 2
2010 2
2011 1
2012 5
2013 4
2014 14
2015 20
2016 19
2017 15
2018 13
2019 14
2020 8
2021 10
2022 13
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera FG, Ronet C, Ochoa de Olza M, Barras D, Crespo I, Andreatta M, Corria-Osorio J, Spill A, Benedetti F, Genolet R, Orcurto A, Imbimbo M, Ghisoni E, Navarro Rodrigo B, Berthold DR, Sarivalasis A, Zaman K, Duran R, Dromain C, Prior J, Schaefer N, Bourhis J, Dimopoulou G, Tsourti Z, Messemaker M, Smith T, Warren SE, Foukas P, Rusakiewicz S, Pittet MJ, Zimmermann S, Sempoux C, Dafni U, Harari A, Kandalaft LE, Carmona SJ, Dangaj Laniti D, Irving M, Coukos G. Herrera FG, et al. Among authors: duran r. Cancer Discov. 2022 Jan;12(1):108-133. doi: 10.1158/2159-8290.CD-21-0003. Epub 2021 Sep 3. Cancer Discov. 2022. PMID: 34479871 Free PMC article.
Tumor response assessment on imaging following immunotherapy.
Berz AM, Dromain C, Vietti-Violi N, Boughdad S, Duran R. Berz AM, et al. Among authors: duran r. Front Oncol. 2022 Oct 25;12:982983. doi: 10.3389/fonc.2022.982983. eCollection 2022. Front Oncol. 2022. PMID: 36387133 Free PMC article. Review.
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Barras D, Ghisoni E, Chiffelle J, Orcurto A, Dagher J, Fahr N, Benedetti F, Crespo I, Grimm AJ, Morotti M, Zimmermann S, Duran R, Imbimbo M, de Olza MO, Navarro B, Homicsko K, Bobisse S, Labes D, Tsourti Z, Andriakopoulou C, Herrera F, Pétremand R, Dummer R, Berthod G, Kraemer AI, Huber F, Thevenet J, Bassani-Sternberg M, Schaefer N, Prior JO, Matter M, Aedo V, Dromain C, Corria-Osorio J, Tissot S, Kandalaft LE, Gottardo R, Pittet M, Sempoux C, Michielin O, Dafni U, Trueb L, Harari A, Laniti DD, Coukos G. Barras D, et al. Among authors: duran r. Sci Immunol. 2024 Feb 2;9(92):eadg7995. doi: 10.1126/sciimmunol.adg7995. Epub 2024 Feb 2. Sci Immunol. 2024. PMID: 38306416
Cryoablation and immunotherapy of cancer.
Yakkala C, Denys A, Kandalaft L, Duran R. Yakkala C, et al. Among authors: duran r. Curr Opin Biotechnol. 2020 Oct;65:60-64. doi: 10.1016/j.copbio.2020.01.006. Epub 2020 Feb 20. Curr Opin Biotechnol. 2020. PMID: 32088576 Review.
Imaging assessment of toxicity related to immune checkpoint inhibitors.
Berz AM, Boughdad S, Vietti-Violi N, Digklia A, Dromain C, Dunet V, Duran R. Berz AM, et al. Among authors: duran r. Front Immunol. 2023 Feb 23;14:1133207. doi: 10.3389/fimmu.2023.1133207. eCollection 2023. Front Immunol. 2023. PMID: 36911692 Free PMC article. Review.
Portal vein embolization: what do we know?
Denys A, Prior J, Bize P, Duran R, De Baere T, Halkic N, Demartines N. Denys A, et al. Among authors: duran r. Cardiovasc Intervent Radiol. 2012 Oct;35(5):999-1008. doi: 10.1007/s00270-011-0300-1. Epub 2011 Dec 16. Cardiovasc Intervent Radiol. 2012. PMID: 22173639 Review.
131 results